首页|期刊导航|Acta Biochimica et Biophysica Sinica|Head-to-head:IL-21 triumphs over IL-15 in NK cell therapy for glioblastoma
Acta Biochimica et Biophysica Sinica2025,Vol.57Issue(4):P.676-678,3.DOI:10.3724/abbs.2025009
Head-to-head:IL-21 triumphs over IL-15 in NK cell therapy for glioblastoma
摘要
关键词
develop more effective therapies/glioblastoma/gbm/head head/temozolomide chemotherapypatient/NK cell therapy/primary brain tumordespite/IL分类
医药卫生引用本文复制引用
Jake C.Miller,Bihui Cao,Jia Shen..Head-to-head:IL-21 triumphs over IL-15 in NK cell therapy for glioblastoma[J].Acta Biochimica et Biophysica Sinica,2025,57(4):P.676-678,3.基金项目
supported by the grants from the Schwarz Family and Friends Cancer Research Fund(to J.S.) (to J.S.)
the Indiana University School of Medicine Start-Up Fund(to J.S.) (to J.S.)
Indiana University EMPOWER grant(to J.S.)。 (to J.S.)